Domantis is nothing new & it has been used before in example i think all management where trying to get at there was not a direct comparison but just highlighting that aside from Galapagos, Evotec etc generating signifcant revenue through their librarys there are also companies that have been jumped early by pharma before anything even reaches the clinic, not saying that is Phylogicas path but just touching on how events have unfolded in this space in the past.
Phenomica is always exciting it's just taken a mighty long time to carry it forward - intention to spin-off 18 months ago & very little news since ?
NAOS stats are interesting obviously the redemptions facing the fund held a different view to its staff - while forced to unload here at a signifcant loss NAOS where actually buying up this year aswell since ceasing to be a sub holder -
02/02/2012 - 51,000,000 shares - 11.5% 30/06/2012 - 65,000,000 shares - 14.2% As of today ? ? ?
Cash is running pretty low though $2.8M as of 30/06/2012, if they don't secure deals or hit any milestones by end of month they'll be looking at capital markets - quarterly expenditures will put them heading towards $1.5M by months end.
PYC Price at posting:
2.4¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)